Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Approved For Marketing NCT06590051

AMG 335 Expanded Access Program for IgG4-Related Disease

Sponsor: Amgen

Summary

Expanded access requests for AMG 335 may be considered for adult patients with a confirmed diagnosis of IgG4-related disease. To request access, use Responsible Party contact information provided in this record.

Eligibility Criteria

Inclusion Criteria: \- Exclusion Criteria: \-

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06590051). StuddyBuddy aggregates publicly available trial information.